Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations
Boston Scientific: Q2 Earnings Snapshot
MARLBOROUGH, Mass. , July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported...
Barchart Research What to Expect from BSX Earnings BSX Generated July 28, 2026 Current Price $46.06 EPS Estimate $$0.83 Consensus Rating Strong Buy Average Move 5.27% Boston Scientific's Restructuring...
What To Expect From Boston Scientific’s (BSX) Q2 Earnings
Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down
1 Stock Under $50 to Keep an Eye On and 2 We Brush Off
Boston Scientific is gearing up for earnings day, weighing a rocky stock run against Wall Street's stubbornly optimistic outlook.